Skip to content
Med Rx.

Nepafenac interactions

Checked as Nepafenac (ophthalmic) in this data source.

Full monograph for NepafenacCheck it against another medicine

Medicines

34 documented

Medicines documented to interact with Nepafenac, worst severity first.
MedicineSeverityMechanismEffectSources
AcalabrutinibModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Allium cepa + Heparin + AllantoinModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
AlteplaseModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
ApixabanModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
AspirinModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Aspirin + DipyridamoleModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…2 documented mechanisms3 sources — open the full entry
BetrixabanModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
BivalirudinModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
CabozantinibModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
CilostazolModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Clopidogrel + AspirinModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…2 documented mechanisms3 sources — open the full entry
Clopidogrel BisulphateModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Dabigatran Etexilate MesylateModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Dalteparin SodiumModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
DasatinibModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Dexamethasone (Ophthalmic)ModerateSynergyConcomitant use of ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) and ophthalmic steroids may increase the potential for healing problems, as both…3 sources — open the full entry
DipyridamoleModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Enoxaparin SodiumModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
EptifibatideModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Fondaparinux SodiumModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Heparin SodiumModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
IbrutinibModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Ponatinib HydrochlorideModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Prasugrel HydrochlorideModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
RamucirumabModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Regorafenib MonohydrateModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
RivaroxabanModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Ruxolitinib (Oral)ModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
StreptokinaseModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
TenecteplaseModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
TicagrelorModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Tirofiban HydrochlorideModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Trastuzumab EmtansineModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry
Warfarin SodiumModerateSynergySystemically and topically administered nonsteroidal anti-inflammatory drugs (NSAIDs) may potentiate the risk of bleeding in patients treated with…3 sources — open the full entry

Conditions

Conditions in which Nepafenac needs care, as documented in this source.